PCA3 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "PCA3" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

11doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

1ensembl.org

1,626^th place

1,007^th place

1aacrjournals.org

8,869^th place

8,487^th place

1europeanurology.com

low place

1zenodo.org

621^st place

380^th place

1reuters.com

49^th place

47^th place

aacrjournals.org

cancerres.aacrjournals.org

Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB (December 1999). "DD3: a new prostate-specific gene, highly overexpressed in prostate cancer". Cancer Research. 59 (23): 5975–9. PMID 10606244.

doi.org

Neves AF, Araújo TG, Biase WK, Meola J, Alcântara TM, Freitas DG, Goulart LR (October 2008). "Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis". Clinical Biochemistry. 41 (14–15): 1191–8. doi:10.1016/j.clinbiochem.2008.06.013. PMID 18640109.
Loeb S (November 2008). "Does PCA3 help identify clinically significant prostate cancer?". European Urology. 54 (5): 980–1. doi:10.1016/j.eururo.2008.07.027. PMID 18684556.
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM (February 2008). "A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer". Cancer Research. 68 (3): 645–9. doi:10.1158/0008-5472.CAN-07-3224. PMC 2998181. PMID 18245462.
Vlaeminck-Guillem V, Ruffion A, Andre J (May 2008). "[Value of urinary PCA3 test for prostate cancer diagnosis]". Progres en Urologie (in French). 18 (5): 259–65. doi:10.1016/j.purol.2008.03.029. PMID 18538269.
Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, Ellis WJ, Marks LS, Fradet Y, Rittenhouse H, Groskopf J (April 2008). "PCA3: a molecular urine assay for predicting prostate biopsy outcome". The Journal of Urology. 179 (4): 1587–92. doi:10.1016/j.juro.2007.11.038. PMID 18295257.
Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M, Feyerabend S, Stillebroer AB, van Gils MP, Schalken JA (November 2008). "Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy". European Urology. 54 (5): 1081–8. doi:10.1016/j.eururo.2008.06.071. PMID 18602209.
Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SM, Cancio AT, Desaulniers M, Ellis WJ, Rittenhouse H, Groskopf J (March 2007). "PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy". Urology. 69 (3): 532–5. doi:10.1016/j.urology.2006.12.014. PMID 17382159.
de la Taille A (September 2007). "Progensa PCA3 test for prostate cancer detection". Expert Review of Molecular Diagnostics. 7 (5): 491–7. doi:10.1586/14737159.7.5.491. PMID 17892357. S2CID 11338727.
Nakanishi H, Groskopf J, Fritsche HA, Bhadkamkar V, Blase A, Kumar SV, Davis JW, Troncoso P, Rittenhouse H, Babaian RJ (May 2008). "PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance". The Journal of Urology. 179 (5): 1804–9, discussion 1809–10. doi:10.1016/j.juro.2008.01.013. PMID 18353398.
van Gils MP, Hessels D, Hulsbergen-van de Kaa CA, Witjes JA, Jansen CF, Mulders PF, Rittenhouse HG, Schalken JA (August 2008). "Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results". The Prostate. 68 (11): 1215–22. doi:10.1002/pros.20781. PMID 18500693. S2CID 38697285.
Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG (November 2008). "PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume". The Journal of Urology. 180 (5): 1975–8, discussion 1978–9. doi:10.1016/j.juro.2008.07.060. PMID 18801539.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000225937 – Ensembl, May 2017

europeanurology.com

Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M, Feyerabend S, Stillebroer AB, van Gils MP, Schalken JA (November 2008). "Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy". European Urology. 54 (5): 1081–8. doi:10.1016/j.eururo.2008.06.071. PMID 18602209.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB (December 1999). "DD3: a new prostate-specific gene, highly overexpressed in prostate cancer". Cancer Research. 59 (23): 5975–9. PMID 10606244.
Neves AF, Araújo TG, Biase WK, Meola J, Alcântara TM, Freitas DG, Goulart LR (October 2008). "Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis". Clinical Biochemistry. 41 (14–15): 1191–8. doi:10.1016/j.clinbiochem.2008.06.013. PMID 18640109.
Loeb S (November 2008). "Does PCA3 help identify clinically significant prostate cancer?". European Urology. 54 (5): 980–1. doi:10.1016/j.eururo.2008.07.027. PMID 18684556.
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM (February 2008). "A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer". Cancer Research. 68 (3): 645–9. doi:10.1158/0008-5472.CAN-07-3224. PMC 2998181. PMID 18245462.
Vlaeminck-Guillem V, Ruffion A, Andre J (May 2008). "[Value of urinary PCA3 test for prostate cancer diagnosis]". Progres en Urologie (in French). 18 (5): 259–65. doi:10.1016/j.purol.2008.03.029. PMID 18538269.
Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, Ellis WJ, Marks LS, Fradet Y, Rittenhouse H, Groskopf J (April 2008). "PCA3: a molecular urine assay for predicting prostate biopsy outcome". The Journal of Urology. 179 (4): 1587–92. doi:10.1016/j.juro.2007.11.038. PMID 18295257.
Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M, Feyerabend S, Stillebroer AB, van Gils MP, Schalken JA (November 2008). "Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy". European Urology. 54 (5): 1081–8. doi:10.1016/j.eururo.2008.06.071. PMID 18602209.
Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SM, Cancio AT, Desaulniers M, Ellis WJ, Rittenhouse H, Groskopf J (March 2007). "PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy". Urology. 69 (3): 532–5. doi:10.1016/j.urology.2006.12.014. PMID 17382159.
de la Taille A (September 2007). "Progensa PCA3 test for prostate cancer detection". Expert Review of Molecular Diagnostics. 7 (5): 491–7. doi:10.1586/14737159.7.5.491. PMID 17892357. S2CID 11338727.
Nakanishi H, Groskopf J, Fritsche HA, Bhadkamkar V, Blase A, Kumar SV, Davis JW, Troncoso P, Rittenhouse H, Babaian RJ (May 2008). "PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance". The Journal of Urology. 179 (5): 1804–9, discussion 1809–10. doi:10.1016/j.juro.2008.01.013. PMID 18353398.
van Gils MP, Hessels D, Hulsbergen-van de Kaa CA, Witjes JA, Jansen CF, Mulders PF, Rittenhouse HG, Schalken JA (August 2008). "Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results". The Prostate. 68 (11): 1215–22. doi:10.1002/pros.20781. PMID 18500693. S2CID 38697285.
Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG (November 2008). "PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume". The Journal of Urology. 180 (5): 1975–8, discussion 1978–9. doi:10.1016/j.juro.2008.07.060. PMID 18801539.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM (February 2008). "A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer". Cancer Research. 68 (3): 645–9. doi:10.1158/0008-5472.CAN-07-3224. PMC 2998181. PMID 18245462.

reuters.com

Soyoung Kim and Anand Basu (30 April 2012). "Hologic to buy Gen-Probe for $3.75 billion". Reuters. Retrieved April 8, 2017.

semanticscholar.org

api.semanticscholar.org

de la Taille A (September 2007). "Progensa PCA3 test for prostate cancer detection". Expert Review of Molecular Diagnostics. 7 (5): 491–7. doi:10.1586/14737159.7.5.491. PMID 17892357. S2CID 11338727.
van Gils MP, Hessels D, Hulsbergen-van de Kaa CA, Witjes JA, Jansen CF, Mulders PF, Rittenhouse HG, Schalken JA (August 2008). "Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results". The Prostate. 68 (11): 1215–22. doi:10.1002/pros.20781. PMID 18500693. S2CID 38697285.

zenodo.org

Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG (November 2008). "PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume". The Journal of Urology. 180 (5): 1975–8, discussion 1978–9. doi:10.1016/j.juro.2008.07.060. PMID 18801539.